Market intelligence for the Slovak pharma market

Drug consumption, reimbursement, competition and patients in the Slovak pharma market — in one dashboard.

Datalytica connects public NCZI, ŠÚKL and MoH SR data into insights for market-access, commercial and BI teams. Every figure carries its source, period and update frequency.

Request a demo See dashboard preview
Data sources: NCZIŠÚKLMZ SR

Every view states its source and period. Datalytica does not work with "today's" data across the board — it reflects the latest published period of each source (consumption quarterly, registries yearly, categorisation proceedings daily).

Market overview SR · 2025
Last available period
Celkový trh+6,2 %
€2,14 mld.
Insurer reimbursement+4,1 %
€1,38 mld.
Predané balenia+2,8 %
312 mil.
Rast medziročneYoY
+5,9 %
Market evolution12 mesiacov
Market by segmentpodiel €
€2,1 mld. ročne
Lieky na predpis38%
Voľnopredajné27%
Zdrav. pomôcky20%
Dietetické15%
Top therapy areaspodiel trhu
Market leadersdržitelia reg.
100 %
public, verifiable data
12+ modules
from category to brand
€ and packages
market shares in both metrics
0 Excelov
no manual data downloads
Problem

Public data exists. The problem is turning it into business insight.

NCZI, ŠÚKL and the MoH SR publish a wealth of data on consumption, prices and reimbursement. But processing it manually is time-consuming, opaque and hard to use for decisions.

Dozens of disjointed Excel exports
Hours of manual cleaning and merging
No single view of the market
Solution

Datalytica turns public data into a clear dashboard.

The platform automatically processes available Slovak data and turns it into market insights that help track competition, shares, trends and opportunities.

Public data
NCZI · ŠÚKL · MZ SR
Processing
cleaning and standardisation
Analytics
shares, trends, competition
Decisions
a clear dashboard
What you see in the platform

From category down to a specific brand.

Who it's for

For teams that need to see the market without unnecessary complexity.

One system that speaks the language of market access, sales and analytics — with no needless onboarding.

Platform previews

See the views you will actually get.

31 views in four groups — from the whole market through competition to diagnoses and regions. Pick a quarter or a full year, with complete lists of molecules and segments. Click to switch between previews.

Datalytica/Celý trh
Last available period

Sample views with real 2025 data. Some views are available in higher plans.

Data and sources

Built on verified public Slovak sources.

Datalytica works with publicly available Slovak data and processes it into usable analytics for decisions on the national market.

NCZI
National Health Information Center — consumption and dispensing.
ŠÚKL
State Institute for Drug Control — registrations and prices.
MZ SR
Ministry of Health SR — reimbursement and categorisation.
Use cases

Data that leads to concrete decisions.

Market-access
Track reimbursement and categorisation
See how insurer reimbursement evolves in your category and where opportunities arise.
Sales
Evaluate market share
Compare your brand with competitors in packages and euros and by dispensing channel.
Strategy
Prepare for the patent cliff
Identify molecules before patent expiry and estimate the market impact.
FAQ

Frequently asked questions

Practical answers to what companies ask most before getting started.

Where does the data come from?
From official public sources — NCZI, ŠÚKL and the Slovak Ministry of Health. We clean, link and aggregate the data into clear dashboards; we work with no non-public or personal data.
Why pay for public data?
Public data is available, but it is not ready for decision-making. Datalytica regularly downloads, cleans and links it via codes (ATC, ŠÚKL, ICD-10), unifies company names, computes shares, trends and segment differences — and shows it in one dashboard, with source and period on every figure. You save dozens of hours of manual work in Excel.
How up to date is the data?
Frequency depends on the source — for every dataset the pricing states which period it covers. NCZI drug consumption, for example, is quarterly. We never show running same-day figures; always closed, verified periods.
Is the platform GDPR-compliant?
Yes. We work exclusively with aggregated, anonymised public market data — no individual patient or sensitive personal data.
How many users can our account have?
The licence is per company with an unlimited number of users — you don't pay per colleague.
Can I export the data?
Yes — in the Pro and Intelligence plans you can download the current view to CSV; Intelligence also includes API access.
How does billing work?
You choose what suits you: annual access (best value — you pay once for 12 months) or quarterly access with no commitment at a higher rate. In both cases you get access to all the data in your plan — historical and continuously updated. We invoice the company billing details you enter at registration. Prices exclude VAT.
Can I see historical data?
Yes. Drug consumption reaches back to 2020 (quarterly), medical devices and dietary foods — packs 2020–2025, reimbursement € 2024–2025, disease registers 2013–2024, oncology 2016–2024. The exact range and the latest available period of every dataset is in the “Data recency & range” table in cenníku (we keep it up to date there). The range of unlocked periods depends on your plan.
How do we get started?
Fill in the Request-a-demo form or register. We activate the account manually and get back to you by e-mail; then you sign in and see the data unlocked according to your subscription.
Contact

Want to see your position on the market?

Get in touch and we'll show you a demo on your own segment — competition, shares and trends over time.

Operator
MEDIBEARS s. r. o.
Ulica J. Bendíka 738/6
971 01 Prievidza, Slovensko
IČO56 818 301
DIČ2122462584
IČ DPHSK2122462584
Registered in the Commercial Register of the District Court Trenčín, section Sro, entry No. 55562/R.
info@datalytica.sk